Sanjay Lakhotia
Fortune : 4 866 $ au 31/01/2026
Fortune : 4 866 $ au 31/01/2026
Sanjay Lakhotia is currently Chief Business Officer at Zenith Capital Corp.
(Alberta) since 2014.
Former positions include Associate Director-Corporate Development at MedImmune LLC, Director-Corporate Development at Onyx Pharmaceuticals, Inc., Senior Director-Corporate Development at Portola Pharmaceuticals LLC, Process Development Engineer at Wyeth Pharmaceuticals LLC, and Vice President-Corporate Development at both Pathway Therapeutics, Inc. and Pathway Therapeutics Ltd. Education includes a doctorate from Northwestern University, an MBA from The University of North Carolina at Charlotte, and an undergraduate degree from the University of California.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZENITH CAPITAL CORP. 0,03% | 31/03/2026 | 48 656 ( 0,03% ) | 4 866 $ | 31/01/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ZENITH CAPITAL CORP. | Corporate Officer/Principal | 01/08/2014 |
| Sociétés | Poste | Fin |
|---|---|---|
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Corporate Officer/Principal | - |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | - |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Pathway Therapeutics, Inc.
Pathway Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer and inflammatory diseases | Health Technology |
Zenith Capital Corp. (Alberta)
Zenith Capital Corp. (Alberta) BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pathway Therapeutics Ltd.
Pathway Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national